Evidence map›Paper›PMID 28271346›Full record

SynthesisNeuropsychology review2017

Non-Pharmacologic Interventions for Older Adults with Subjective Cognitive Decline: Systematic Review, Meta-Analysis, and Preliminary Recommendations.

Colette M Smart, Justin E Karr, Corson N Areshenkoff, Laura A Rabin, Carol Hudon, Nicola Gates, Jordan I Ali, Eider M Arenaza-Urquijo, Rachel F Buckley, Gael Chetelat and 8 more

Open access · greenAbstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Neuropsychology review, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 8 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 8 syntheses or guidelines pooled it, 148 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 7 countries.

Colette M SmartDepartment of Psychology, University of Victoria, PO Box 1700, STN CSC, Victoria, BC, V8W 2Y2, Canada. csmart@uvic.ca.
Justin E KarrDepartment of Psychology, University of Victoria, PO Box 1700, STN CSC, Victoria, BC, V8W 2Y2, Canada.
Corson N AreshenkoffDepartment of Psychology, University of Victoria, PO Box 1700, STN CSC, Victoria, BC, V8W 2Y2, Canada.
Laura A RabinBrooklyn College and The Graduate Center of The City University of New York, New York, NY, USA.
Carol HudonUniversite Laval, Quebec City, QC, Canada.
Nicola GatesUniversity of New South Wales, Sydney, Australia.
Jordan I AliDepartment of Psychology, University of Victoria, PO Box 1700, STN CSC, Victoria, BC, V8W 2Y2, Canada.
Eider M Arenaza-UrquijoINSERM, U1077, 14074, Caen, France.
Rachel F BuckleyFlorey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.
Gael ChetelatINSERM, U1077, 14074, Caen, France.
Harald HampelAXA Research Fund and UPMC Chair, Sorbonne Universities, Pierre et Marie Curie University, Paris, France.
Frank JessenDepartment of Psychiatry, University of Cologne, Medical Faculty, Cologne, Germany.
Natalie L MarchantDivision of Psychiatry, University College London, London, England, UK.
Sietske A M SikkesAlzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands.
Andrea TalesSwansea University, Swansea, Wales, UK.
Wiesje M van der FlierAlzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands.
Linda WesselmanAlzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands.
and the Subjective Cognitive Decline Initiative (SCD-I) Working Group
University of Victoria · CAAmsterdam Neuroscience · NLHarvard University · USInserm · FRSwansea University · GBThe Graduate Center, CUNY · USUniversity of Cologne · DEUNSW Sydney · AU

Funding

Alzheimer Society 1216
6 · The paper itself

Abstract

In subjective cognitive decline (SCD), older adults present with concerns about self-perceived cognitive decline but are found to have clinically normal function. However, a significant proportion of those adults are subsequently found to develop mild cognitive impairment, Alzheimer's dementia or other neurocognitive disorder. In other cases, SCD may be associated with mood, personality, and physical health concerns. Regardless of etiology, adults with SCD may benefit from interventions that could enhance current function or slow incipient cognitive decline. The objective of this systematic review and meta-analysis, conducted in accordance with the PRISMA guidelines, is to examine the benefits of non-pharmacologic intervention (NPI) in persons with SCD. Inclusion criteria were studies of adults aged 55 + with SCD defined using published criteria, receiving NPI or any control condition, with cognitive, behavioural, or psychological outcomes in controlled trails. Published empirical studies were obtained through a standardized search of CINAHL Complete, Cochrane Central Register of Controlled Trials, MEDLINE with Full Text, PsycINFO, and PsycARTICLES, supplemented by a manual retrieval of relevant articles. Study quality and bias was determined using PEDro. Nine studies were included in the review and meta-analysis. A wide range of study quality was observed. Overall, a small effect size was found on cognitive outcomes, greater for cognitive versus other intervention types. The available evidence suggests that NPI may benefit current cognitive function in persons with SCD. Recommendations are provided to improve future trials of NPI in SCD.

Indexed as

AgedBehavior TherapyCognitive DysfunctionComplementary TherapiesHumansAlzheimer’s diseaseCognitive interventionsComplementary therapiesMild cognitive impairmentTreatment outcome

Identifiers

PMID28271346
OpenAlexW2593974732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.